valu usd unless otherwis note
slow start lead back-end load year
view continu make progress strateg initi
oper improv took step back guidanc
maintain continu nois visibl impact
slightli reduc estim lower pt
miss slower volum growth decemb show
adj ep expect despit tailwind
lower tax rate share count headwind lower
pharmaci reimburs challeng uk oper environ
consist expect script volum came light
quarter lead shortfal
guidanc maintain nois
back-end load
encourag script trend show improv sinc quarter
end month decemb exceed growth target
said despit improv core busi trend time
pbm contract true-up normal issu bonu accrual vs
benefit revers accrual creat ep
headwind typic stronger model
reflect half ep come
management remain confid expect continu improv
 script retail trend along increas save
overhead reduct procur howev continu
anticip level skeptic deliv anticip ramp
transform manag program remain track
exceed save
management reiter forecast program deliv total
save headcount reduct store optim better
extern resourc manag program combin
effort reduc work capit remov excess inventori
initi improv cash flow gener multipl year
save enabl compani invest growth
labcorp healthcar
see np score util better expect
labcorp patient servic center locat strong sale lift
pilot store management also pleas result clinic
servic pilot partner primari villagemd
price prior trade day market close estimate unless otherwis note
bloomberg capit market estim upside/downside/target
target base adjust ep
repres discount two-year averag
peer group valuat essenti consist current
reason consid on-going challeng face
compani articul well-defin
strategi begin demonstr success
expect investor assign significantli higher valuat
stock given near-term headwind like
limit near-term earn growth use basi
recogn manag confid sustain mid-
upsid scenario assum ep growth
come high end manag target long-
term rang mid-to-high singl digit reflect better-
than-expect abil off-set on-going challeng
oper environ analysi also assum
investor becom comfort manag
strategi compani abil execut valuat
multipl return peer group two-year averag
level
downsid scenario assum ep growth
come slightli manag long-term guidanc
unabl gener anticip top-lin growth
cost save analysi assum stock
valuat declin approxim discount rel
comp group two-year averag level
believ signific nation scale brand
posit benefit on-going shift toward
consumer healthcar provid care
patient conveni set focu qualiti
effici becom increasingli import
manag recogn evolv role commun
pharmaci import deliv broader suit
servic product focus health well
effort creat neighborhood health destin
form valuabl strateg partnership leverag
expertis leader import servic non-cor
compet compani import
opinion primari care partnership
could help posit compani well rapidli
proprietari analysi conjunct element
show solid overlap sever attract market
high densiti walgreen store strong
membership howev believ abil scale
partnership key ensur relev evolv
marketplac futur success
evid materi progress turnaround cost
reduct effort could result upward estim revis
believ well-defin strategi specif
financi target could improv market percept
stori valuat
resolut opioid litig exposur issu would remov
overhang share
improv clariti regard brexit could improv
consum environ boot uk
risk invest thesi
inabl gener anticip cost save could hamper
abil invest capit growth-ori
failur creat neighborhood health destin
target inabl scale model
no-deal brexit could weaken uk retail
amazon entri drug deliveri could impact revenu
earn growth rate pharmaci busi
wba adjust ep fell short estim consensu
despit tailwind lower tax rate share count rel
manag expect miss driven lower pharmaci script like due
shift aetna govern busi well calendar impact
late thanksgiv support improv trend decemb result also reflect
continu impact lower pharmaci reimburs challeng
oper environ uk partli off-set solid cost control
manag re-affirmed ep essenti flat yoy despit miss
addit nois confid back-half ramp driven primarili improv
volum sg save run rate doubl year-end prescript volum
oper show strong improv decemb trend expect rang
year support notion holiday time affect perform
also provid confid mgmt volum target anticip benefit
strong posit medicar advantag pdp member recent
partnership medicaid recent renew contract prime
commerci help off-set volum loss due aetna busi shift
said despit improv core busi trend continu experi nois
cycl time reimburs payment bonu accrual creat
estim ep headwind assum guidanc recal
guidanc previous assum yoy growth oper perform
contribut buyback off-set reinstat full bonus headwind
higher tax rate yoy rel assumpt manag expect less
unfavor tax impact better sg perform partli off-set lower gpm due
save transform manag program appear track
robust pipelin opportun initi gain momentum area
acceler energi manag effici ramp procur activ good
resal store vendor optim manag increasingli confid
save exceed target run-rat overhead reduct doubl
year-end enabl off-set known headwind
cost inflat volum loss relat yoy bonu accrual
increment invest addit free cash flow quarter
exceed manag target hundr million compani multi-year
opportun drive improv work capit reduct also
help invest growth
continu progress strateg partnership encourag initi result kroger
conveni pilot northern kentucki east tennesse recent form
gpo procur privat label good manag expect deliv cost save
suppli chain effici labcorp psc locat plan also
continu deliv improv np score util addit partnership
open second five villagemd primari care locat
houston also note strong perform compani co-brand product
offer
transform role pharmacist longer play acceler roll-out
pharmaci system order free pharmacist workload help transform role
deliveri healthcar previous discuss compani current pharmacist
network focus achiev perform outcom alreadi see increas
reimburs certain mco pbm effort particularli part
manag expect perform network deliv materi impact
insur pbm increasingli realiz valu deliv lower cost care
yoy
yoy
top-line somewhat weaker expect pharmaci slow
retail sale continu improv vs despit continu neg
impact store optim program
adj oi margin bp yoy reflect known headwind bonu accrual
well mtm adjust defer comp time supplier fund
spike spread evenli throughout item combin
ep headwind quarter
adj gpm bp yoy larg driven continu pressur
pharmaci reimburs consist expect well headwind relat
continu strong growth specialti carri lower margin
said management note continu progress wba initi off-set pharmaci
reimburs pressur includ procur save overhead cost reduct
adj sg bp yoy
ss script growth expect slow
howev management note nice improv sinc quarter end script growth
solid mid-singl digit month decemb
also continu experi solid growth specialti yoy addit brand
inflat appear consist mgmt expect partli off-set mid-
high-singl digit gener deflationari impact outperform gener market
pharmaci market share declin bp yoy attribut primarili
store optim program
exclud tobacco e-cigarett retail ss show continu
improv strength core well ss beauti ss
well favor cough/cold flu season ad bp
despit improv top-line perform retail adj gpm declin slightli due increas
shrink unfavor comp vs prior year supplier fund
yoy constant currenc
consist recent quarter yoy top-line declin reflect challeng oper
environ particularli uk market
improv vs partli driven increas nh fund partli off-set
management note boot volum affect decis exit certain
lower-margin loss-mak servic focus sustain profit custom
retent better expect
compani roll proprietari pharmaci oper system boot
uk store enabl better custom servic effici eventu new pharmaci
boot continu hold market share midst declin uk retail oper
management note improv perform expect flagship store reinvent
beauti offer sinc rebalanc space boot largest
yoy cc
adj oi margin bp bp yoy consist last quarter yoy margin
boot complet half target closur under-perform store
deliv increas save throughout
recal store closur repres boot uk footprint mani store
involv lose money within walk distanc anoth boot store
anticip revenu impact closur management note custom
retent follow store closur encourag
yoy cc
wholesal segment continu post solid top-line perform led emerg
market uk
note compani anniversari previous discuss custom contract
ad yoy revenu growth
yoy cc
adj oi margin bp yoy
strateg jv
management expect jv help drive long-term valu key european market
accret ep intermedi term acceler segment long-term earn
price target base multipl adjust ep repres
approxim discount two-year averag peer group valuat essenti
consist current forward multipl believ discount valuat reason
consid on-going challeng face compani abl
articul well-defin strategi begin demonstr success
expect investor assign significantli higher valuat stock given near-term
headwind like limit near-term earn growth use basi
recogn manag confid sustain mid- high-single-digit ep growth
price target justifi sector perform rate
risk rate price target
may abl deliv anticip save transform
manag program hamper abil invest capit growth-ori
manag may find right mix product servic fail creat
neighborhood health destin target compani partner may
abl scale model quickli enough protect market share
uk retail environ could remain soft weaken undermin manag
effort reinvigor busi
on-going nation policy-driven effort reduc drug price could unintend
consequ retail pharmaci busi model
amazon could continu erod front-stor busi entri drug deliveri
could significantli reduc wba revenu earn growth rate pharmaci
largest retail pharmaci health daili live destin
across us europ walgreen boot allianc compani
equiti method invest togeth presenc countri employ
peopl compani global leader pharmacy-l health
well-b retail togeth equiti method invest
store countri well one largest global pharmaceut wholesal
distribut network distribut center deliv
pharmaci doctor health center hospit year
countri addit one world largest purchas
prescript drug mani health well-b product
sale
adj sg sale
equiti earn
